Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;39(6):1225-1232.
doi: 10.1007/s10815-022-02467-3. Epub 2022 Mar 31.

Effect of A23187 ionophore treatment on human blastocyst development-a sibling oocyte study

Ileana Mateizel  1 , Samuel Santos-Ribeiro  2 , Ingrid Segers  3 , Koen Wouters  3 , Shari Mackens  3 , Greta Verheyen  3
Affiliations

Effect of A23187 ionophore treatment on human blastocyst development-a sibling oocyte study

Ileana Mateizel et al. J Assist Reprod Genet. 2022 Jun.

Abstract

Purpose: To investigate whether treatment with commercially available ready-to-use A23187 ionophore (GM508-CultActive) improves embryo development outcome in patients with a history of embryo developmental problems.

Methods: This is a uni-center prospective study in which sibling oocytes of patients with embryos of poor quality on day 5 in the previous cycle were treated or not with CultActive.

Results: Two hundred forty-seven metaphase II (MII) oocytes from 19 cycles performed between 2016 and 2019 were included in the study. After ICSI, the sibling oocytes were assigned to the treatment group or to the control group, following an electronically generated randomization list. A number of 122 MII were treated with CultActive and 125 MII had no treatment and were assigned to the control group. No difference in fertilization rate (p = 0.255) or in the capacity of embryos to reach good quality on day 5 (p = 0.197) was observed between the two groups. The utilization rates defined as the number of embryos transferred or cryopreserved per mature oocyte (p = 0.438) or per fertilized oocytes (p = 0.299) were not significantly different between the treated group and the control group.

Conclusion: The results of the current study do not support the use of CultActive in cases with embryo developmental problems.

Keywords: A23187 ionophore; Assisted oocyte activation; Blastocyst development; CultActive.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Saunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney ML, Swann K, Lai FA. PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development. 2002;129(15):3533–3544. doi: 10.1242/dev.129.15.3533. - DOI - PubMed
    1. Swann K, Larman MG, Saunders CM, Lai FA. The cytosolic sperm factor that triggers Ca2+ oscillations and egg activation in mammals is a novel phospholipase C: PLCzeta. Reproduction. 2004;127:431–439. doi: 10.1530/rep.1.00169. - DOI - PubMed
    1. Yeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activation deficiency: a role for an oocyte contribution? Hum Reprod Update. 2016;22(1):23–47. doi: 10.1093/humupd/dmv040. - DOI - PubMed
    1. Whitaker M. Calcium at fertilization and in early development. Physiol Rev. 2006;86(1):25–88. doi: 10.1152/physrev.00023.2005. - DOI - PMC - PubMed
    1. Jones KT. Intracellular calcium in the fertilization and development of mammalian eggs. Clin Exp Pharmacol Physiol. 2007;34(10):1084–1089. doi: 10.1111/j.1440-1681.2007.04726. - DOI - PubMed

LinkOut - more resources